Response to the letter by Lai et al. regarding our manuscript "Statin use and pancreatic cancer risk in two prospective cohort studies".
作者信息
Hamada Tsuyoshi, Ogino Shuji, Wolpin Brian M
机构信息
Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
出版信息
J Gastroenterol. 2020 Apr;55(4):473-474. doi: 10.1007/s00535-020-01676-w. Epub 2020 Feb 14.
Abstract
摘要
相似文献
1
Response to the letter by Lai et al. regarding our manuscript "Statin use and pancreatic cancer risk in two prospective cohort studies".对赖等人就我们的手稿《两项前瞻性队列研究中的他汀类药物使用与胰腺癌风险》所写信件的回复。
J Gastroenterol. 2020 Apr;55(4):473-474. doi: 10.1007/s00535-020-01676-w. Epub 2020 Feb 14.
2
Statin use and pancreatic cancer risk in two prospective cohort studies.他汀类药物的使用与两种前瞻性队列研究中的胰腺癌风险。
J Gastroenterol. 2018 Aug;53(8):959-966. doi: 10.1007/s00535-018-1430-x. Epub 2018 Jan 23.
3
Statins and pancreatic cancer risk.他汀类药物与胰腺癌风险。
J Gastroenterol. 2020 Apr;55(4):471-472. doi: 10.1007/s00535-020-01675-x. Epub 2020 Feb 8.
4
Prospective analysis of association between statins and pancreatic cancer risk in the Women's Health Initiative.妇女健康倡议中他汀类药物与胰腺癌风险关联的前瞻性分析。
Cancer Causes Control. 2016 Mar;27(3):415-23. doi: 10.1007/s10552-016-0717-6. Epub 2016 Feb 9.
5
The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom.他汀类药物对胰腺癌发病风险的差异影响：英国两个中心的病例对照研究。
Dig Dis Sci. 2013 Nov;58(11):3308-12. doi: 10.1007/s10620-013-2778-7. Epub 2013 Jul 18.
6
Statins and pancreatic cancer risk: a nested case-control study.他汀类药物与胰腺癌风险：一项巢式病例对照研究。
Cancer Causes Control. 2010 Dec;21(12):2093-100. doi: 10.1007/s10552-010-9628-0. Epub 2010 Aug 10.
7
Statins and the risk of pancreatic cancer in Type 2 diabetic patients--A population-based cohort study.他汀类药物与2型糖尿病患者患胰腺癌的风险——一项基于人群的队列研究。
Int J Cancer. 2016 Feb 1;138(3):594-603. doi: 10.1002/ijc.29813. Epub 2015 Aug 31.
8
Statin Use and Risk of Pancreatic Cancer: An Updated Meta-analysis of 26 Studies.他汀类药物的使用与胰腺癌风险：26项研究的最新荟萃分析
Pancreas. 2019 Feb;48(2):142-150. doi: 10.1097/MPA.0000000000001226.
9
Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database.他汀类药物使用与癌症的相关性：自发报告数据库和索赔数据库的数据挖掘。
Int J Med Sci. 2015 Jan 22;12(3):223-33. doi: 10.7150/ijms.10656. eCollection 2015.
10
Statin Exposure and Pancreatic Cancer Incidence: A Japanese Regional Population-Based Cohort Study, the Shizuoka Study.他汀类药物暴露与胰腺癌发病风险：一项日本区域性基于人群的队列研究，即静冈研究。
Cancer Prev Res (Phila). 2021 Sep;14(9):863-872. doi: 10.1158/1940-6207.CAPR-21-0123. Epub 2021 Jul 9.
本文引用的文献
1
Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.分支状-乳头部管状乳头状黏液性肿瘤的长期恶性风险。
Gastroenterology. 2020 Jan;158(1):226-237.e5. doi: 10.1053/j.gastro.2019.08.032. Epub 2019 Aug 29.
2
Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.微生物学、分子病理学和流行病学的整合：探索微生物组驱动型肿瘤发病机制的新模式。
J Pathol. 2019 Apr;247(5):615-628. doi: 10.1002/path.5236. Epub 2019 Feb 20.
3
Statin use and pancreatic cancer risk in two prospective cohort studies.他汀类药物的使用与两种前瞻性队列研究中的胰腺癌风险。
J Gastroenterol. 2018 Aug;53(8):959-966. doi: 10.1007/s00535-018-1430-x. Epub 2018 Jan 23.
4
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.主要驱动基因改变与接受胰腺导管腺癌切除术患者结局的关系。
JAMA Oncol. 2018 Mar 8;4(3):e173420. doi: 10.1001/jamaoncol.2017.3420.
5
Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies.根据两项大型前瞻性队列研究中的分子亚型，他汀类药物的使用与结直肠癌风险。
Cancer Prev Res (Phila). 2011 Nov;4(11):1808-15. doi: 10.1158/1940-6207.CAPR-11-0113. Epub 2011 Jun 16.
Zotero 插件